Position in AZN
as of Jun 30, 2026
· filed Aug 20, 2026
Position Value
$1,949,862
+$569,125 QoQ
Shares Held
10,283
+46.9% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.23%
of 13F equity value
Holder Rank
#539
of 1,462 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AZN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Rehmann Capital Advisory Group holds $37,318,224 across 12 Drug Manufacturers - General names. AZN ranks #8 (5.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
38,703 | $9,829,400 | |
| 2 | LLY |
ELI LILLY & Co
|
5,246 | $6,292,210 | |
| 3 | MRK |
Merck & Co., Inc.
|
29,611 | $3,805,013 | |
| 4 | PFE |
Pfizer Inc
|
152,066 | $3,661,749 | |
| 5 | ABBV |
AbbVie Inc.
|
12,987 | $3,268,048 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
42,344 | $2,439,861 | |
| 7 | AMGN |
Amgen Inc
|
6,083 | $2,202,775 | |
| 8 | AZN |
Astrazeneca PLC
This page
|
10,283 | $1,949,862 |
All Filings in AZN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,949,862 | 10,283 | Shares | Sole | 2026-08-20 | |
| 2026-03-31 | $1,380,737 | 7,001 | Shares | Sole | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||